Shares in the Nasdaq-listed company rose 5% at market open on 13 January compared to a pre-announcement market close. Dexcom released the news ahead of a presentation at the JP Morgan Healthcare ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

DXCM's top line reflects strong demand for its CGM sensors. International expansion is also driving sales higher. Gross margin reflects inventory damage.

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Kratky is a 5-star analyst with an average return of 28.1% and a 66.67% success rate. Kratky covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Dexcom, and Edwards ...